Cargando…

Characterizing the Experience of Tapentadol Nonmedical Use: Mixed Methods Study

BACKGROUND: The prevalence of abuse, diversion, and web-based endorsement of tapentadol (extended-release [ER], immediate-release [IR]) has been characterized as low compared with other prescription opioids. Little is known about individual experience with tapentadol nonmedical use (NMU). OBJECTIVE:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vosburg, Suzanne K, Dailey-Govoni, Taryn, Beaumont, Jared, Butler, Stephen F, Green, Jody L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233245/ https://www.ncbi.nlm.nih.gov/pubmed/35687397 http://dx.doi.org/10.2196/16996

Ejemplares similares

Evaluation of Abuse and Route of Administration of Extended-Release Tapentadol Among Treatment-Seeking Individuals, as Captured by the Addiction Severity Index–Multimedia Version (ASI-MV)
por: Vosburg, Suzanne K, et al.
Publicado: (2019)

Real-World Data on Nonmedical Use of Tramadol from Patients Evaluated for Substance Abuse Treatment in the NAVIPPRO Addiction Severity Index—Multimedia Version (ASI-MV(®)) Network
por: Green, Jody L., et al.
Publicado: (2020)

Characterizing prescription stimulant nonmedical use (NMU) among adults recruited from Reddit
por: Vosburg, Suzanne K., et al.
Publicado: (2021)

Nonmedical Use of Xtampza(®) ER and Other Oxycodone Medications in Adults Evaluated for Substance Abuse Treatment: Real-World Data from the Addiction Severity Index-Multimedia Version (ASI-MV(®))
por: Green, Jody L, et al.
Publicado: (2021)

Associations between prescription stimulant use as prescribed, nonmedical use, and illicit stimulant use among adults evaluated for substance use treatment, 2017-2021
por: Pickens, Cassandra M., et al.
Publicado: (2023)

How Motivations for Using Buprenorphine Products Differ From Using Opioid Analgesics: Evidence from an Observational Study of Internet Discussions Among Recreational Users
por: Butler, Stephen F, et al.
Publicado: (2020)

Characterizing Pathways of Non-oral Prescription Stimulant Non-medical Use Among Adults Recruited From Reddit
por: Vosburg, Suzanne K., et al.
Publicado: (2021)

Tapentadol: an overview of the safety profile
por: Polati, Enrico, et al.
Publicado: (2019)

Application of Design of Experiment for Floating Drug Delivery of Tapentadol Hydrochloride
por: Jagdale, Swati C., et al.
Publicado: (2013)

Nonmedical use of prescription drugs: A comparison between intoxication-oriented and other nonmedical users
por: Piispa, Ilona, et al.
Publicado: (2021)

Tapentadol hydrochloride: A novel analgesic
por: Singh, Dewan Roshan, et al.
Publicado: (2013)

Outcomes of the Pediatric Development Plan of Tapentadol
por: Eerdekens, Mariëlle, et al.
Publicado: (2021)

Nonmedical use of sedatives in urban Bengaluru
por: Nattala, Prasanthi, et al.
Publicado: (2014)

Macular Burns from Nonmedical Lasers
por: Sayman Muslubaş, Işıl, et al.
Publicado: (2016)

Influence of radiology expertise on the perception of nonmedical images
por: Kelly, Brendan, et al.
Publicado: (2017)

Tapentadol: an effective option for the treatment of back pain
por: Coluzzi, Flaminia, et al.
Publicado: (2019)

Characteristics of Adults Aged ≥18 Years Evaluated for Substance Use and Treatment Planning — United States, 2019
por: Kacha-Ochana, Akadia, et al.
Publicado: (2022)

Promoting Reproducible Research for Characterizing Nonmedical Use of Medications Through Data Annotation: Description of a Twitter Corpus and Guidelines
por: O'Connor, Karen, et al.
Publicado: (2020)

Twitter Analysis of the Nonmedical Use and Side Effects of Methylphenidate: Machine Learning Study
por: Kim, Myeong Gyu, et al.
Publicado: (2020)

A Novel Algorithm to Identify Predictors of Treatment Response: Tapentadol Monotherapy or Tapentadol/Pregabalin Combination Therapy in Chronic Low Back Pain?
por: Otto, Jan C., et al.
Publicado: (2019)

Nonmedical prescriber experiences of training and competence to report adverse drug reactions in the UK
por: Thompson, Andrew, et al.
Publicado: (2018)

Prevalence of nonmedical methamphetamine use in the United States
por: Durell, Todd M, et al.
Publicado: (2008)

Coming to terms with the nonmedical use of prescription medications
por: Boyd, Carol J, et al.
Publicado: (2008)

Nonmedical Uses of Antibiotics: Time to Restrict Their Use?
por: Meek, Richard William, et al.
Publicado: (2015)

Nonmedical use of prescription drugs in the European Union
por: Novak, Scott P., et al.
Publicado: (2016)

Tapentadol Prolonged Release for Long-Term Treatment of Pain in Children
por: Howard, Richard F, et al.
Publicado: (2020)

Patient considerations in the use of tapentadol for moderate to severe pain
por: Vadivelu, Nalini, et al.
Publicado: (2013)

Prediction of response to tapentadol in chronic low back pain
por: Reimer, M., et al.
Publicado: (2016)

Tapentadol Prolonged Release: A Review in Pain Management
por: Deeks, Emma D.
Publicado: (2018)

Tapentadol: an effective option for the treatment of back pain [Corrigendum]
Publicado: (2019)

Tapentadol extended release for the management of chronic neck pain
por: Billeci, Domenico, et al.
Publicado: (2017)

Comparison of tapentadol with tramadol for analgesia after cardiac surgery
por: Iyer, Srinivas Kalyanaraman, et al.
Publicado: (2015)

Tapentadol for neuropathic pain: a review of clinical studies
por: Freo, Ulderico, et al.
Publicado: (2019)

Tapentadol in the treatment of osteoarthritis: pharmacological rationale and clinical evidence
por: Rinonapoli, Giuseppe, et al.
Publicado: (2019)

Tapentadol, the new kid on the block in India: Is it time to worry?
por: Basu, Debasish, et al.
Publicado: (2020)

Trends in dispensing and utilisation of sustained-release tapentadol in Australia.
por: Camacho, Ximena, et al.
Publicado: (2022)

Web-Based Discussion and Illicit Street Sales of Tapentadol and Oxycodone in Australia: Epidemiological Surveillance Study
por: Black, Joshua, et al.
Publicado: (2021)

Today’s nonmedical opioid users are not yesterday’s patients; implications of data indicating stable rates of nonmedical use and pain reliever use disorder
por: Singer, Jeffrey A, et al.
Publicado: (2019)

Comparative Efficacy of Tapentadol versus Tapentadol Plus Duloxetine in Patients with Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Randomized Non-Inferiority Clinical Trial
por: Sansone, Pasquale, et al.
Publicado: (2022)

Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis
por: Anderson, Laurie S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4u7vag42cc6ao4rn3ve1nem1ec